2023. Gypenosides improved inflammatory status, insulin resistance and hepatic steatosis in obese C57BL/6J mice : Gypenosides improved inflammatory status in obese mice. Journal of Food Bioactives. 21, (Mar. 2023). DOI:https://doi.org/10.31665/JFB.2023.18337.